Pendulum Therapeutics
Latest round
- Series C
Last raised
- Apr 2021
Total raised
- $119M
Investors
- 8
About Pendulum Therapeutics
Pendulum Therapeutics, Inc.Pendulum Therapeutics, Inc. specializes in innovative probiotic solutions for gut health and metabolic support. Founded in 2013 in San Francisco, US, by Colleen Cutcliffe, James Bullard, and John Eid, the company has completed a total of 6 deals.Pendulum primarily offers a range of next-generation probiotics designed to promote gut health and improve metabolic functions. Their flagship product, Glucose Control, is clinically shown to enhance A1C levels in individuals with type 2 diabetes, distinguishing itself as the only medical probiotic with such evidence. Other core offerings include Metabolic Daily, which aims to boost metabolism, and Akkermansia, which replenishes important gut strains. These products are designed for varying end users, including individuals managing diabetes and those seeking to improve their overall gut health.Pendulum generates revenue through a subscription-based model, where customers can opt for recurring deliveries of their products, ensuring a steady supply for ongoing health management. The typical transaction structure involves direct-to-consumer sales via their online platform, allowing for easy access and order management. Pricing plans reflect the membership structure, with products like Metabolic Daily priced competitively to appeal to both individual users and healthcare providers. Customers can choose from various subscription options, such as monthly or quarterly deliveries, which encourage long-term engagement with the products.Pendulum Therapeutics, Inc. Plans include launching new probiotics tailored to specific metabolic health needs and expanding into additional international markets, with a strong focus on Europe and Asia. The company intends to release new products by the end of 2024, aligning with their growth strategy to broaden their customer base.
Who invested in Pendulum Therapeutics
8 investors across 5 rounds
See all investors in Pendulum Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pendulum Therapeutics
Who invested in Pendulum Therapeutics?
Pendulum Therapeutics has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pendulum Therapeutics raised?
Pendulum Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Pendulum Therapeutics last raise money?
Pendulum Therapeutics's most recent round on record is a Series C, in Apr 2021.
What does Pendulum Therapeutics do?
Pendulum Therapeutics is a biotechnology company.
Where is Pendulum Therapeutics headquartered?
Pendulum Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Pendulum Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pendulum Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Pendulum Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.